chrX-631191-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000451.4(SHOX):​c.277+17T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.974 in 1,612,446 control chromosomes in the GnomAD database, including 764,790 homozygotes. There are 779,154 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.97 ( 71631 hom., 72226 hem., cov: 34)
Exomes 𝑓: 0.97 ( 693159 hom. 706928 hem. )

Consequence

SHOX
NM_000451.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.909

Publications

0 publications found
Variant links:
Genes affected
SHOX (HGNC:10853): (SHOX homeobox) This gene belongs to the paired homeobox family and is located in the pseudoautosomal region 1 (PAR1) of X and Y chromosomes. Defects in this gene are associated with idiopathic growth retardation and in the short stature phenotype of Turner syndrome patients. This gene is highly conserved across species from mammals to fish to flies. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008]
SHOX Gene-Disease associations (from GenCC):
  • Leri-Weill dyschondrosteosis
    Inheritance: XL, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Langer mesomelic dysplasia
    Inheritance: Unknown, XL, AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • SHOX-related short stature
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant X-631191-T-G is Benign according to our data. Variant chrX-631191-T-G is described in ClinVar as Benign. ClinVar VariationId is 93092.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.97 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000451.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SHOX
NM_000451.4
MANE Select
c.277+17T>G
intron
N/ANP_000442.1
SHOX
NM_006883.2
c.277+17T>G
intron
N/ANP_006874.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SHOX
ENST00000686671.1
MANE Select
c.277+17T>G
intron
N/AENSP00000508521.1
SHOX
ENST00000381575.6
TSL:1
c.277+17T>G
intron
N/AENSP00000370987.1
SHOX
ENST00000381578.6
TSL:5
c.277+17T>G
intron
N/AENSP00000370990.1

Frequencies

GnomAD3 genomes
AF:
0.970
AC:
147558
AN:
152152
Hom.:
71581
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.960
Gnomad AMI
AF:
0.988
Gnomad AMR
AF:
0.975
Gnomad ASJ
AF:
0.921
Gnomad EAS
AF:
0.949
Gnomad SAS
AF:
0.953
Gnomad FIN
AF:
0.989
Gnomad MID
AF:
0.981
Gnomad NFE
AF:
0.977
Gnomad OTH
AF:
0.973
GnomAD2 exomes
AF:
0.970
AC:
241076
AN:
248660
AF XY:
0.969
show subpopulations
Gnomad AFR exome
AF:
0.958
Gnomad AMR exome
AF:
0.986
Gnomad ASJ exome
AF:
0.917
Gnomad EAS exome
AF:
0.947
Gnomad FIN exome
AF:
0.988
Gnomad NFE exome
AF:
0.976
Gnomad OTH exome
AF:
0.966
GnomAD4 exome
AF:
0.974
AC:
1422506
AN:
1460176
Hom.:
693159
Cov.:
58
AF XY:
0.973
AC XY:
706928
AN XY:
726360
show subpopulations
African (AFR)
AF:
0.961
AC:
32148
AN:
33470
American (AMR)
AF:
0.986
AC:
44088
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.921
AC:
24073
AN:
26132
East Asian (EAS)
AF:
0.949
AC:
37683
AN:
39696
South Asian (SAS)
AF:
0.951
AC:
82001
AN:
86244
European-Finnish (FIN)
AF:
0.987
AC:
51439
AN:
52122
Middle Eastern (MID)
AF:
0.950
AC:
5424
AN:
5708
European-Non Finnish (NFE)
AF:
0.978
AC:
1087111
AN:
1111746
Other (OTH)
AF:
0.970
AC:
58539
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
2079
4159
6238
8318
10397
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21656
43312
64968
86624
108280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.970
AC:
147667
AN:
152270
Hom.:
71631
Cov.:
34
AF XY:
0.970
AC XY:
72226
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.960
AC:
39925
AN:
41590
American (AMR)
AF:
0.975
AC:
14917
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.921
AC:
3195
AN:
3468
East Asian (EAS)
AF:
0.948
AC:
4862
AN:
5126
South Asian (SAS)
AF:
0.953
AC:
4596
AN:
4824
European-Finnish (FIN)
AF:
0.989
AC:
10512
AN:
10626
Middle Eastern (MID)
AF:
0.983
AC:
289
AN:
294
European-Non Finnish (NFE)
AF:
0.976
AC:
66412
AN:
68012
Other (OTH)
AF:
0.974
AC:
2058
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
237
475
712
950
1187
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
912
1824
2736
3648
4560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Bravo
AF:
0.969

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 25, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:4
Jul 13, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Nov 06, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 30, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Leri-Weill dyschondrosteosis Benign:1
Sep 10, 2025
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
1.6
DANN
Benign
0.14
PhyloP100
-0.91
PromoterAI
-0.0018
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2239402; hg19: chrX-591926; API